31 signals · newsapi, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Auto-generated from public signals — AI summary pending. Based on 3 recent signals.
Insilico Medicine Teams Up with Value Partners Shenzhen to Form Fund, Committing CNY 302.5 Million to Biomedical and AI Investments BigGo Finance
InSilico Medicine Commits RMB302.5 Million to New Investment Fund TipRanks
Insilico Medicine Shares Undervalued? Board Approves HK$500 Million Buyback BigGo Finance
Artificial intelligence for drug discovery and aging.
Based on 31 signals across 2 sources · snapshot 4 Nov 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for Insilico Medicine is positive based on public signals as of 4 Nov 2026.
Based on 31 signals across 2 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Board Approves HK$500 Million Buyback BigGo Finance